Labeling and identification of LNCaP cell surface proteins: A pilot study

Prostate

Volumn 67, Issue 9, 2007, Pages 943-954

  Whitaker, Hayley C ^a   Stanbury, David P B ^a   Brinham, Claire ^b   Girling, Joanne ^a   Hanrahan, Sarah ^c   Totty, Nick ^c   Neal, David E ^a  

^a CANCER RESEARCH UK CAMBRIDGE RESEARCH INSTITUTE   (United Kingdom)

^b UNIVERSITY OF YORK   (United Kingdom)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Androgen regulation; Biotinylation; Membrane proteins

Indexed keywords

ANDROGEN; BICALUTAMIDE; BIOTIN; CELL SURFACE PROTEIN; GLUCOSE REGULATED PROTEIN 78; LOW DENSITY LIPOPROTEIN RECEPTOR; MEMBRANE PROTEIN; METRIBOLONE; PROTEIN PRX3; UNCLASSIFIED DRUG; UVOMORULIN;

ARTICLE; BIOTINYLATION; CELL COMPARTMENTALIZATION; CELL FRACTIONATION; CELL STRAIN LNCAP; CELL SURFACE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MASS SPECTROMETRY; MICROSCOPY; PILOT STUDY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; PROTEIN PURIFICATION; TWO DIMENSIONAL GEL ELECTROPHORESIS; VALIDATION PROCESS; WESTERN BLOTTING;

ANDROGENS; BIOTINYLATION; CELL LINE, TUMOR; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; MALE; MEMBRANE PROTEINS; METRIBOLONE; NEOPLASM PROTEINS; PILOT PROJECTS; PROSTATIC NEOPLASMS;

EID: 34249703367     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.20580     Document Type: Article

References (46)

1. Hewett PW. Identification of tumour-induced changes in endothelial cell surface protein expression: An in vitro model. hit J Biochem Cell Biol 2001;33(4):325-335.
2. Shin BK, Wang H, Yim AM, Le Naour F, Brichory F, Jang JH, Zhao R, Puravs E, Tra J, Michael CW, Misek DE, Hanash SM. Global profiling of the cell surface proteome of cancer cells uncovers an abundance of proteins with chaperone function. J Biol Chem 2003;278(9):7607-7616.
3. Zhao Y, Zhang W, Kho Y. Proteomic analysis of integral plasma membrane proteins. Anal Chem 2004;76(7):1817-1823.
4. Sabarth N, Lamer S, Zimny-Arndt U, Jungblut PR, Meyer TF, Bumann D. Identification of surface proteins of Helicobacter pylori by selective biotinylation, affinity purification, and two-dimensional gel electrophoresis. J Biol Chem 2002;277(31):27896-27902.
5. Cunha GR, Donjacour AA, Cooke PS, Mee S, Bigsby RM, Higgins SJ, Sugimura Y. The endocrinology and developmental biology of the prostate. Endocr Rev 1987;8(3):338-362.
6. Papatsoris AG, Karamouzis MV, Papavassiliou AG. Novel insights into the implication of the IGF-1 network in prostate cancer. Trends Mol Med 2005;11(2):52-55.
7. Royuela M, Ricote M, Parsons MS, Garcia-Tunon I, Paniagua R, de Miguel MP. Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasia and malignant human prostate. J Pathol 2004;202(1):41-49.
8. Nagano K, Masters JR, Akpan A, Yang A, Corless S, Wood C, Hastie C, Zvelebil M, Cramer R, Naaby-Hansen S. Differential protein synthesis and expression levels in normal and neoplastic human prostate cells and their regulation by type I and II interferons. Oncogene 2004;23(9):1693-1703.
9. Lin B, White JT, Lu W, Xie T, Utleg AG, Yan X, Yi EC, Shannon P, Khrebtukova I, Lange PH, Goodlett DR, Zhou D, Vasicek TJ, Hood L. Evidence for the presence of disease-perturbed networks in prostate cancer cells by genomic and proteomic analyses: A systems approach to disease. Cancer Res 2005;65(8):3081-3091.
10. Bainbridge MN, Warren RL, Hirst M, Romanuik T, Zeng T, Go A, Delaney A, Griffith M, Hickenbotham M, Magrini V, Mardis ER, Sadar MD, Siddiqui AS, Marra MA, Jones SJ. Analysis of the prostate cancer cell line LNCaP transcriptome using a sequencing-by-synthesis approach. BMC Genomics 2006;7:246.
11. Dehm SM, Tindall DJ. Molecular regulation of androgen action in prostate cancer. J Cell Biochem 2006;99(2):333-344.
12. Kuruma H, Egawa S, Oh-Ishi M, Kodera Y, Maeda T. Proteome analysis of prostate cancer. Prostate Cancer Prostatic Dis 2005;8(1):14-21.
13. Horoszewicz JS, Leong SS, Kawinski E, Karr JP, Rosenthal H, Chu TM, Mirand EA, Murphy GP. LNCaP model of human prostatic carcinoma. Cancer Res 1983;43(4):1809-1818.
14. Peehl D. Human prostatic epithelial and stromal cell lines and strains. Urol Oncol 1996;2(4):99-128.
15. Wright ME, Eng J, Sherman J, Hockenbery DM, Nelson PS, Galitski T, Aebersold R. Identification of androgen-coregulated protein networks from the microsomes of human prostate cancer cells. Genome Biol 2003;5(1):R4.
16. Waghray A, Feroze F, Schober MS, Yao F, Wood C, Puravs E, Krause M, Hanash S, Chen YQ. Identification of androgen-regulated genes in the prostate cancer cell line LNCaP by serial analysis of gene expression and proteomic analysis. Proteomics 2001;1(10):1327-1338.
17. Johansson B, Pourian MR, Chuan YC, Byman I, Bergh A, Pang ST, Norstedt G, Bergman T, Pousette A. Proteomic comparison of prostate cancer cell lines LNCaP-FGC and LNCaP-r reveals heatshock protein 60 as a marker for prostate malignancy. Prostate 2006;66(12):1235-1244.
18. Gelmann EP, Semmes OJ. Expression of genes and proteins specific for prostate cancer. J Urol 2004;172(5 Pt 2):S23-S26 discussion S26-S27.
19. Whitaker HC, Hanrahan S, Totty N, Gamble SC, Waxman J, Cato AC, Hurst HC, Bevan CL. Androgen receptor is targeted to distinct subcellular compartments in response to different therapeutic antiandrogens. Clin Cancer Res 2004;10(21):7392-7401.
20. Roobol A, Grantham J, Whitaker HC, Carden MJ. Disassembly of the cytosolic chaperonin in mammalian cell extracts at intracellular levels of K+ and ATP. J Biol Chem 1999;274(27):19220-19227.
21. Craven RA, Hanrahan S, Totty N, Harnden P, Stanley AJ, Maher ER, Harris AL, Trimble WS, Selby PJ, Banks RE. Proteomic identification of a role for the von Hippel Lindau tumour suppressor in changes in the expression of mitochondrial proteins and septin 2 in renal cell carcinoma. Proteomics 2006;6(13):3880-3893.
22. Sabio G, Arthur JS, Kuma Y, Peggie M, Carr J, Murray-Tait V, Centeno F, Goedert M, Morrice NA, Cuenda A. p38gamma regulates the localisation of SAP97 in the cytoskeleton by modulating its interaction with GKAP. Embo J 2005;24(6):1134-1145.
23. Efanov AM, Sewing S, Bokvist K, Gromada J. Liver X receptor activation stimulates insulin secretion via modulation of glucose and lipid metabolism in pancreatic beta-cells. Diabetes 2004;53 (Suppl 3) S75-S78.
24. Carruba G, Miceli D, D'Amico D, Farruggio R, Comito L, Montesanti A, Polito L, Castagnetta LA. Sex steroids up-regulate E-cadherin expression in hormone-responsive LNCaP human prostate cancer cells. Biochem Biophys Res Commun 1995;212(2):624-631.
25. Nightingale J, Chaudhary KS, Abel PD, Stubbs AP, Romanska HM, Mitchell SE, Stamp GW, Lalani el N. Ligand activation of the androgen receptor downregulates E-cadherin-mediated cell adhesion and promotes apoptosis of prostatic cancer cells. Neoplasia 2003;5(4):347-361.
26. Umbas R, Isaacs WB, Bringuier PP, Schaafsma HE, Karthaus HF, Oosterhof GO, Debruyne FM, Schalken JA. Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Res 1994;54(14):3929-3933.
27. Misra UK, Gonzalez-Gronow M, Gawdi G, Pizzo SV. The role of MTJ-1 in cell surface translocation of GRP78, a receptor for alpha 2-macroglobulin-dependent signaling. J Immunol 2005;174(4):2092-2097.
28. Smith DF, Sullivan WP, Marion TN, Zaitsu K, Madden B, McCormick DJ, Toft DO. Identification of a 60-kilodalton stress-related protein, p60, which interacts with hsp90 and hsp70. Mol Cell Biol 1993;13(2):869-876.
29. Seaman MN, Sowerby PJ, Robinson MS. Cytosolic and membrane-associated proteins involved in the recruitment of AP-1 adaptors onto the trans-Golgi network. J Biol Chem 1996;271(41):25446-25451.
30. van Noort M, Rommerts FF, van Amerongen A, Wirtz KW. Localization and hormonal regulation of the non-specific lipid transfer protein (sterol carrier protein 2) in the rat testis. J Endocrinol 1986;109(3):R13-R16.
31. Wood ZA, Schroder E, Robin Harris J, Poole LB. Structure, mechanism, and regulation of peroxiredoxins. Trends Biochem Sci 2003;28(1):32-40.
32. Liu L, Yang C, Yuan J, Chen X, Xu J, Wei Y, Yang J, Lin G, Yu L. RPK118, a PX domain-containing protein, interacts with peroxiredoxin-3 through pseudo-kinase domains. Mol Cells 2005;19(1):39-45.
33. Nonn L, Berggren M, Powis G. Increased expression of mitochondrial peroxiredoxin-3 (thioredoxin peroxidase-2) protects cancer cells against hypoxia and drug-induced hydrogen peroxide-dependent apoptosis. Mol Cancer Res 2003;1(9):682-689.
34. Choi JH, Kim TN, Kim S, Baek SH, Kim JH, Lee SR, Kim JR. Overexpression of mitochondrial thioredoxin reductase and peroxiredoxin III in hepatocellular carcinomas. Anticancer Res 2002;22(6A):3331-3335.
35. Kaighn M, Narayan K, Ohnuki Y, Lechner J, Jones L. Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 1979;17(1):16-23.
36. Bussemakers MJ, Van Bokhoven A, Tomita K, Jansen CF, Schalken JA. Complex cadherin expression in human prostate cancer cells. Int J Cancer 2000;85(3):446-450.
37. Umbas R, Schalken JA, Aalders TW, Carter BS, Karthaus HF, Schaafsma HE, Debruyne FM, Isaacs WB. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res 1992;52(18):5104-5109.
38. Koksal IT, Ozcan F, Kilicaslan I, Tefekli A. Expression of E-cadherin in prostate cancer in formalin-fixed, paraffin-embedded tissues: Correlation with pathological features. Pathology 2002;34(3):233-238.
39. Zanata SM, Lopes MH, Mercadante AF, Hajj GN, Chiarini LB, Nomizo R, Freitas AR, Cabral AL, Lee KS, Juliano MA, de Oliveira E, Jachieri SG, Burlingame A, Huang L, Linden R, Brentani RR, Martins VR. Stress-inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection. Embo J 2002;21(13):3307-3316.
40. Mintz PJ, Kim J, Do KA, Wang X, Zinner RG, Cristofanilli M, Arap MA, Hong WK, Troncoso P, Logothetis CJ, Pasqualini R, Arap W. Fingerprinting the circulating repertoire of antibodies from cancer patients. Nat Biotechnol 2003;21(1):57-63.
41. Miyake H, Hara I, Arakawa S, Kamidono S. Stress protein GRP78 prevents apoptosis induced by calcium ionophore, ionomycin, but not by glycosylation inhibitor, tunicamycin, in human prostate cancer cells. J Cell Biochem 2000;77(3):396-408.
42. Swinnen JV, Verhoeven G. Androgens and the control of lipid metabolism in human prostate cancer cells. J Steroid Biochem Mol Biol 1998;65(1-6):191-198.
43. Misra UK, Deedwania R, Pizzo SV. Activation and cross-talk between Akt, NF-kappaB, and unfolded protein response signaling in 1-LN prostate cancer cells consequent to ligation of cell surface-associated G RP78. J Biol Chem 2006;281(19):13694-13707.
44. Pootrakul L, Datar RH, Shi SR, Cai J, Hawes D, Groshen SG, Lee AS, Cote RJ. Expression of stress response protein Grp 78 is associated with the development of castration-resistant prostate cancer. Clin Cancer Res 2006;12(20 Pt 1):5987-5993.
45. Araki M, Nanri H, Ejima K, Murasato Y, Fujiwara T, Nakashima Y, Ikeda M. Antioxidant function of the mitochondrial protein SP-22 in the cardiovascular system. J Biol Chem 1999;274(4):2271-2278.
46. Schroeder F, Zhou M, Swaggerty CL, Atshaves BP, Petrescu AD, Storey SM, Martin GG, Huang H, Helmkamp GM, Ball JM. Sterol carrier protein-2 functions in phosphatidylinositol transfer and signaling. Biochemistry 2003;42(11):3189-3202.